Reduced NGF secretion by HT-29 human colon cancer cells treated with a GRPR antagonist

Protein and Peptide Letters

Volumn 16, Issue 6, 2009, Pages 650-652

  De Farias, Caroline Brunetto ^a   Stertz, Laura ^a   Lima, Rodrigo Cruz ^a   Kapczinski, Flávio ^a   Schwartsmann, Gilberto ^a   Roesler, Rafael ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Colon cancer; Gastrin releasing peptide receptor; Nerve growth factor; RC 3095

Indexed keywords

BOMBESIN; BOMBESIN (6 14), TPI(6) LEU(13) PSI(CH2NH) LEU(14); BOMBESIN (6-14), TPI(6)-LEU(13)-PSI(CH2NH)-LEU(14)-; BOMBESIN RECEPTOR; DRUG DERIVATIVE; NERVE GROWTH FACTOR; NGF PROTEIN, HUMAN; PEPTIDE FRAGMENT;

ANALYSIS OF VARIANCE; ARTICLE; CELL STRAIN HT29; DOSE RESPONSE; DRUG ANTAGONISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; SECRETION;

ANALYSIS OF VARIANCE; BOMBESIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; HT29 CELLS; HUMANS; NERVE GROWTH FACTOR; PEPTIDE FRAGMENTS; RECEPTORS, BOMBESIN;

EID: 67650135506     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986609788490177     Document Type: Article

References (10)

1. Cornelio, D.B.; Roesler, R.; Schwartsmann, G. Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy. Ann. Oncol., 2007, 18(9), 1457-1466.
2. Patel, O.; Shulkes, A.; Baldwin, G.S. Gastrin-releasing peptide and cancer. Biochim. Biophys. Acta, 2006, 1766(1), 23-41.
3. Radulovic, S.; Miller, G.; Schally, A.V. Inhibition of growth of HT-29 human colon cancer xenografts in nude mice by treatment with bombesin/gastrin releasing peptide antagonist (RC-3095). Cancer Res., 1991, 51(21), 6006-6009.
4. Radulovic, S.; Schally, A.V.; Reile, H.; Halmos, G.; Szepeshazi, K.; Groot, K.; Milovanovic, S.; Miller, G.; Yano, T. Inhibitory effects of antagonists of bombesin/gastrin releasing peptide (GRP) and somatostatin analog (RC-160) on growth of HT-29 human colon cancers in nude mice. Acta Oncol., 1994, 33(6), 693-701.
5. Descamps, S.; Toillon, R.A.; Adriaenssens, E.; Pawlowski, V.; Cool, S.M.; Nurcombe, V.; Le Bourhis, X.; Boilly, B.; Peyrat, J.P.; Hondermarck, H. Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways. J. Biol. Chem., 2001, 276(21), 17864-17870.
6. Papatsoris, A.G.; Liolitsa, D.; Deliveliotis, C. Manipulation of the nerve growth factor network in prostate cancer. Expert Opin. Investig. Drugs, 2007, 16(3), 303-309.
7. Lipnik-Stangelj, M.; Carman-Krzan, M. Histamine-stimulated nerve growth factor secretion from cultured astrocyctes is blocked by protein kinase C inhibitors. Inflamm. Res., 2004, 53(Suppl 1), S57-S58.
8. Fernando, A.; Farias, C.B.; Roesler, R.; Schwartsmann, G. Targeting the epidermal growth factor receptor in colorectal cancer: a potential therapeutic role for gastrin-releasing peptide receptor antagonists. Oncology, 2007, 72(3-4), 160-161.
9. Flores, D.G.; Leites, J.; Farias, C.B.; Oliveira, M.S.; Lima, R.C.; Tamajusuku, A.S.K.; DiLeone, L.P.; Meurer, L.; Brunetto, A.L.; Schwartsmann, G.; Lenz, G.; Roesler, R. Gastrin-releasing peptide receptors regulate proliferation of C6 glioma cells through a phos- phatidylinositol 3-kinase-dependent mechanism. Curr. Neurovasc. Res., 2008, 5(2), 99-105.
10. Casanueva, F.F.; Perez, F.R.; Casabiell, X.; Camina., J.P.; Cai, R.Z.; Schally. A.V. Correlation between the effects of bombesin antagonists on cell proliferation and intracellular calcium concentration in Swiss 3T3 and HT-29 cell lines. Proc. Natl. Acad. Sci. USA, 1996, 93(4), 1406-1411.